Package insert. Tegretol. Geigy Pharmaceuticals, Division of Ciba-Geigy Corporation, Ardsley, New York, 1984.
7.
AlbrightPBurnhamW. Development of a new pharmacological seizure model: Effects on cortical- and amygdala-kindled seizures in the rat. Epilepsia1980; 21: 681–9.
8.
KoellaWLevinPBaltzerV. The pharmacology of carbamazepine and some other antiepileptic drugs. In: BirkmayerW, ed. Epileptic seizures-behavior-pain. Berne: Hans Huber Publishers, 1975: 32–48.
9.
BallengerJPostR. Carbamazepine in manic-depressive illness: A new treatment. Am J Psychiatry1980; 137: 782–90.
10.
KruppP. The effect of Tegretol on some elementary neuronal mechanisms. Headache1969; 9: 42–6.
11.
TheobaldWKruppPLevinP. Neuropharmacology aspects of the therapeutic action of carbamazepine in trigeminal neuralgia. In: HasslerRWalkerA, eds. Trigeminal neuralgia: Pathogenesis and pathophysiology. Stutgart: Thieme, 1970.
12.
FrommGKillianJ. Effect of some anticonvulsant drugs on the spinal trigeminal nucleus. Neurology1967; 17: 275–80.
13.
Hernandez-PeonR. Central action of G32883 upon transmission of trigeminal pain impulses. Med Pharmacol Exp1965; 12: 73–80.
14.
TheobaldWKunzH. On the pharmacology of the antiepileptic 5-carbamoyl-5-H-dibenzo[b,f]azepine. Arzneimittelforsch1963; 13: 122–5.
15.
HolmVHeinemannHHamannK. Electrophysiological studies of the action of Tegretol on the central nervous system. Naunyn Schmiedebergs Arch Pharmacol1969; 263: 223–4.
16.
BabingtonRHorovitzZ. Neuropharmacology of SQ 10,996, a compound with several therapeutic indications. Arch Int Pharmacodyn Ther1973; 202: 106–18.
17.
GonzalezM Garcia-Pardo. Contribution to the treatment of the psychic aspects of epileptic origin: The value of Tegretol. Acta Luso-Espanolas de Neurologia1964; 3: 246–60.
18.
DemetrescuMJulienR. Local anesthesia and experimental epilepsy. Epilepsia1974; 15: 235–48.
19.
KobayashiKIwataYMukowaJ. Preferential action of Tegretol to limbic seizure. Brain and Nerve (Tokyo)1967; 19: 199–205.
20.
PostR. Carbamazepine's acute and prophylactic effects in manic and depressive illness: An update. Int Drug Ther Newslett1982; 17: 5–10.
21.
PostRBallengerJUhdeTSmithCRubinowDBunneyW. Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatr1982; 17: 1037–45.
22.
BallengerJPostR. Therapeutic effects of carbamazepine in affective illness: A preliminary report. Commn Psychopharmacol1978; 2: 159–75.
23.
TakezakiHHanaokaM. The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic-depressive states. Clin Psychiatry1971; 13: 173–83.
24.
OkumaTKishimotoA. Anti-manic and prophylactic effects of Tegretol. Abstracts VI, World Congress of Psychiatry, Honolulu, Hawaii, 1977.
25.
FolksDGKingLDDowdySB. Carbamazepine treatment of selected affectively disordered inpatients. Am J Psychiatry1982; 139: 115–7.
26.
LipinskiJPopeH. Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients. Am J Psychiatry1982; 139: 948–9.
27.
PostRMUhdeTWBallengerJCSquillaceKM. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry1983; 140: 1602–4.
28.
KishimotoAOguraCHazamaHInoueK. Long-term prophylactic effects of carbamazepine in affective disorders. Br J Psychiatry1983; 143: 327–31.
29.
BunneyWHambergD. Method for reliable longitudinal observation of behavior. Arch Gen Psychiatry1963; 9: 280–94.
30.
FawcettJKravitzHM. The long-term management of bipolar disorders with lithium, carbamazepine and antidepressants. J Clin Psychiatry1985; 46: 58–60.
31.
OkumaTInanagaKOtsukiS. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study. Psychopharmacology1979; 66: 212–17.
32.
TakahashiRSakumaAKozoI. Comparison of lithium carbonate and chlorpromazine in mania. Arch Gen Psychiatry1975; 32: 1310–8.
33.
ToruM. Side effects of psychotropic drugs: An analysis of data obtained from double-blind comparative studies in Japan. Seishin Igaku1974; 16: 659–64.
34.
OkumaTInanagaKOtsukiS. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology1981; 13: 95–6.
35.
PostRBallengerJUhdeTBunneyW. Efficacy of carbamazepine in manic-depressive illness; implications for underlying mechanisms. In: PostRBallengerJ, eds. Neurobiology of mood disorders. Baltimore: Williams and Wilkins, 1983: 777–816.
36.
FordGBiederL. Exfoliative dermatitis due to carbamazepine (Tegretol). NZ Med J1968; 68: 386–7.
37.
HarmanR. Carbamazepine (Tegretol) drug eruptions. Br J Dermatol1967; 79: 500–1.
38.
PisciottaA. Hematologic toxicity of carbamazepine. Complex partial seizures and their treatment. Adv Neurol1975; 11: 355–66.
BeermanBEdhagO. Depressive effects of carbamazepine on idioventricular rhythm in man. Br Med J1978; 2: 171–2.
42.
PostRMUhdeTWBallengerJCChatterjiDCGreeneRFBunneyWE. Carbamazepine and is −10,11-epoxide metabolite in plasma and CSF: Relationship to antidepressant response. Arch Gen Psychiatry1983; 40: 673–6.
43.
GagneuxA. The chemistry of carbamazepine. In: BirkmayerW, ed. Epileptic seizures-behavior-pain. Berne: Hans Huber, 1976: 120–6.
44.
EichelbaumMBertilsonLRaneASojoqvistF. Autoinduction of carbamazepine metabolism in man. In: Anticonvulsant drugs and enzyme induction. Amsterdam/New York: Associated Scientific Publishers, 1976: 147–58.
45.
JohannessenS. Antiepileptic drugs: Pharmacokinetics and clinical aspects. Ther Drug Monitor1981; 3: 17–37.
46.
BertilssonL. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet1978; 3: 128–43.
47.
McCullochJA. An approach to the patient with sciatica. In: GenantHK, ed. Spine update 1984: Perspectives in radiology, orthopaedic surgery, and neurosurgery. San Francisco: Radiology Research and Education Foundation, 1983: 19–22.
LivermoreNB. Low back pain syndrome: A clinical overview. In: GenantHK, ed. Spine update 1984: Perspectives in radiology, orthopaedic surgery, and neurosurgery. San Francisco: Radiology Research and Education Foundation, 1983: 23–34.
50.
WoodKM. New approaches to treatment of back pain. West J Med1979; 130: 394–8.
GreenLN. Dexamethasone in the management of symptoms due to herniated lumbar disc. J Neurol Neurosurg Psychiatry1975; 38: 1211–7.
53.
StamboughJLBoothRERothmanRH. Transient hypercorticism after epidural steroid injection. J Bone Joint Surg (Am)1984; 66A: 1115–6.
54.
WilkinsonHASchumanN. Intradiscal corticosteroids in the treatment of lumbar and cervical disc problems. Spine1980; 5: 385–9.
55.
WhiteAH. Injection techniques for the diagnosis and treatment of low back pain. Orthop Clin North Am1983; 14: 553–67.
56.
HartmanJTWinnieAPRamaurthySManiMRMeyersHLJr. Intradural and extradural corticosteroids for sciatic pain. Orthop Rev1974; 3: 21–4.
57.
BrownFW. Management of diskogenic pain using epidural and intrathecal steroids. Clin Orthop1977; 129: 72–8.
58.
DilkeTFWBarryHCGrahameR. Extradural corticosteroid injection in management of lumbar nerve root compression. Br Med J1973; 2: 635–7.
59.
CucklerJMBerniniPAWieselSWBoothRERothmanRHPickensGT. The use of epidural steroids in the treatment of lumbar radicular pain: A prospective, randomized, double-blind study. J Bone Joint Surg (Am)1985; 67A: 63–6.
60.
BermanATGarbarinoJLFisherSMBosaccoSJ. The effects of epidural injection of local anesthetics and corticosteroids on patients with lumbosciatic pain. Clin Orthop1984; 188: 144–51.
61.
Sayle-CreekWSwerdlowM. Epidural injections for the relief of lumbosciatic pain. Acta Orthop Belg1969; 35: 728–34.
62.
HarleyC. Extradural corticosteroid infiltration: A follow-up study of 50 cases. Ann Phys Med1967; 9: 22–8.
63.
HuntingtonCTCohnMLByrdSE. Combined use of epidural morphine steroid in recurrent postsurgical low back pain syndrome (abstract). Anesth Analg1982; 61: 191.
